Related Experiment Video
Updated: Oct 12, 2026

Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing
Published on: December 11, 2017
Medical devices; revocation of cardiac pacemaker registry. Food and Drug Administration, HHS. Final rule
Insights
The Food and Drug Administration (FDA) is revoking the cardiac pacemaker registry requirement. This change eliminates duplicative reporting for pacemaker device performance tracking and Medicare administration.
Area of Science:
- Medical Device Regulation
- Public Health Policy
Background:
- A cardiac pacemaker registry was mandated by the Deficit Reduction Act of 1984.
- The registry required physicians and service providers to submit data for pacemaker device implantation, removal, or replacement.
- Data was used by the FDA for performance tracking and by HCFA for Medicare administration.
Purpose of the Study:
- To implement a 1996 congressional act to repeal an unnecessary medical device reporting requirement.
- To revoke the regulation mandating the cardiac pacemaker registry.
- To eliminate duplicative and unnecessary reporting burdens.
Main Methods:
- Issuance of a final rule by the Food and Drug Administration (FDA).
- Revocation of a previously established regulation.
- Removal of data submission requirements for cardiac pacemaker devices and leads.
Main Results:
- The cardiac pacemaker registry requirement has been officially revoked.
- Physicians and service providers are no longer required to submit data to the registry.
- Elimination of duplicative reporting for medical device oversight.
Conclusions:
- The FDA's final rule removes an outdated and redundant reporting requirement.
- This action streamlines medical device oversight and reduces administrative burden.
- Focus shifts to more efficient methods for tracking pacemaker device performance and safety.
Abstract:
The Food and Drug Administration (FDA) is issuing a final rule to revoke a regulation requiring a cardiac pacemaker registry. The registry, which was mandated by the Deficit Reduction Act of 1984, requires any physician and any provider of services who requests or receives Medicare payment for an implantation, removal, or replacement of permanent cardiac pacemaker devices and pacemaker leads to submit certain information to the registry. The information is used by FDA to track the performance of permanent cardiac pacemakers and pacemaker leads and by the Health Care Finance Administration (HCFA) to administer its Medicare payment program for these devices. This action is being taken to implement an act to Repeal An Unnecessary Medical Device Reporting Requirement passed by Congress in 1996 to remove the cardiac pacemaker registry to eliminate duplicative and unnecessary reporting.
Related Concept Videos
FDA Approved Drugs: Changes to Approved Drugs
Drug Regulation
Good Manufacturing Practices
Clinically Relevant Drug Product Specifications: Methods of Establishment
Standards of Care II
Regulation of Heart Rates
The SNS increases heart rate through the release of norepinephrine and epinephrine, which act on beta-1 adrenergic receptors in the heart. This action increases the rate of depolarization in the sinoatrial (SA) node, the heart's...
